CARBOPLATIN , FLUOROURACIL , JNJ-61186372, CISPLATIN , PEMBROLIZUMAB
61186372HNC3001
Phase 3 small_molecule active
Quick answer
CARBOPLATIN , FLUOROURACIL , JNJ-61186372, CISPLATIN , PEMBROLIZUMAB for Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active